Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques

Annals of Surgical Oncology

Volumn 17, Issue 7, 2010, Pages 1957-1963

  Ortega Deballon, Pablo ^a,b   Facy, Olivier ^a,b   Jambet, Sophie ^a,b   Magnin, Guy ^b   Cotte, Eddy ^c   Beltramo, Jean L ^d   Chauffert, Bruno ^a   Rat, Patrick ^a,b  

^a Institut Médical de Génétique et d Immunologie   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c University Hospitals of Lyon   (France)

^d CSAB   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIPLATIN; PLATINUM; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; DRUG ABSORPTION; FEMALE; HYPERTHERMIA; HYPERTHERMIC THERAPY; NONHUMAN; OPERATION DURATION; SURGICAL TECHNIQUE; ANIMAL; COMPARATIVE STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; PERITONEAL CAVITY; SWINE; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ABDOMINAL CAVITY; ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; ORGANOPLATINUM COMPOUNDS; SWINE; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 77954951307     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0937-z     Document Type: Article

References (22)

1. Verwaal VJ, Bruin S, Boot H, et al. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2009;15:2426-32.
2. Esquivel J. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea. Cancer J. 2009;15:249-54.
3. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681-5.
4. Cao C, Yan TD, Black D, et al. A systematic review and metaanalysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16:2152-65.
5. Sugarbaker PH. Building on a consensus. J Surg Oncol. 2008;98:215-6.
6. Esquivel J, Elias D, Baratti D, et al. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol. 2008;98:263-7.
7. Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon's role. Langenbecks Arch Surg. 1999;384:576-87.
8. Glehen O, Cotte E, Kusamura S, et al. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol. 2008;98:242-6.
9. Elias D, Antoun B, Goharin A, et al. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Invest. 2000;1:431-9.
10. Benoit L, Cheynel N, Ortega-Deballon P, et al. Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs. Ann Surg Oncol. 2008;15:542-6.
11. Ortega-Deballon P, Facy O, Rat P. A "happy marriage" between open and closed techniques of heated intraperitoneal chemotherapy. Cancer J. 2009;15:448.
12. Ortega-Deballon P, Facy O, Magnin G, et al. Using a heating cable within the abdomen to make hyperthermic intraperitoneal chemotherapy easier: feasibility and safety study in a pig model. Eur J Surg Oncol. (in press).
13. Cotte E, Passot G, Mohamed F, et al. Management of peritoneal carcinomatosis from colorectal cancer: current state of practice. Cancer J. 2009;15:243-8.
14. Elias D, Bonnay M, Puizillou JM, et al. Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetic and tissue distribution. Ann Oncol. 2002;13:267-72. (Pubitemid 34704979)
15. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol. 1998;14:254-61.
16. Sugarbaker PH, Landy D, Jaffe G, et al. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer. 1990;65:1495-501.
17. Gesson-Paute A, Ferron G, Thomas F, et al. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol. 2008;15:339-44.
18. Thomas F, Ferron G, Gesson-Paute A, et al. Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15:3623-4.
19. Esquis P, Consolo D, Magnin G, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244:106-12.
20. Sarnaik AA, Sussman JJ, Ahmad SA, McIntyre BC, Lowy AM. Technology for the delivery of hyperthermic intraoperative intraperitoneal chemotherapy: a survey of techniques. Recent Results Cancer Res. 2007;169:75-82.
21. Rat P, Benoit L, Cheynel N, et al. La chimiothérapie intrapériále à ventre ouvert et avec "dé bordement." Ann Chir. 2001;126:669-71.
22. Ferron G, Dattez S, Gladieff L, et al. Pharmacokinetics of heated intraperitoneal oxaliplatin. Cancer Chemother Pharmacol. 2008;62:679-83.